Covid policy paper 2022 – Lessons learned

Key BIOS facts and Figures – 2022

Scientific advice for continuous innovation in known molecules

Medicines for Europe letter to EC on Divisionals & Patent Linkage re Fingolimod – 13.04.2022

Removing access barriers in Central and Eastern Europe – April 2022

Factsheet: The EU Bolar Exemption

Note on Transferable Vouchers – April 2022

Advancing Medicines repurposing in the EU

Repurposing has emerged as an important strategy to address unmet medical need. Yet, there is still significant untapped potential for its application in the EU.



Creating a European ecosystem

Policy recommendations on uptake of biosimilar medicines in the retail market